[{"id":"370e6b2e-796f-4e1b-a0c3-f76e727397f4","acronym":"","url":"https://clinicaltrials.gov/study/NCT00436280","created_at":"2021-01-18T01:32:22.047Z","updated_at":"2024-07-02T16:36:42.265Z","phase":"Phase 2","brief_title":"Chemotherapy for Participants With Lymphoma","source_id_and_acronym":"NCT00436280","lead_sponsor":"Eli Lilly and Company","biomarkers":" CD20 • PRKCH • PRKCB","pipe":"","alterations":" ","tags":["CD20 • PRKCH • PRKCB"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e gemcitabine • Rituxan (rituximab) • oxaliplatin • Kinenza (enzastaurin)"],"overall_status":"Completed","enrollment":" Enrollment 68","initiation":"Initiation: 02/01/2007","start_date":" 02/01/2007","primary_txt":" Primary completion: 11/01/2009","primary_completion_date":" 11/01/2009","study_txt":" Completion: 11/01/2012","study_completion_date":" 11/01/2012","last_update_posted":"2020-08-06"},{"id":"0a7b2fa7-a40c-474b-8236-37798e0d2949","acronym":"","url":"https://clinicaltrials.gov/study/NCT00088205","created_at":"2021-01-18T00:15:39.042Z","updated_at":"2024-07-02T16:36:43.664Z","phase":"Phase 2","brief_title":"Oral Enzastaurin in Participants With Relapsed Mantle Cell Lymphoma","source_id_and_acronym":"NCT00088205","lead_sponsor":"Eli Lilly and Company","biomarkers":" PRKCH • PRKCB","pipe":"","alterations":" ","tags":["PRKCH • PRKCB"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Kinenza (enzastaurin)"],"overall_status":"Completed","enrollment":" Enrollment 60","initiation":"Initiation: 03/01/2004","start_date":" 03/01/2004","primary_txt":" Primary completion: 05/01/2008","primary_completion_date":" 05/01/2008","study_txt":" Completion: 05/01/2008","study_completion_date":" 05/01/2008","last_update_posted":"2020-07-01"},{"id":"73313447-d37a-4a29-95ba-cbf690bc106a","acronym":"","url":"https://clinicaltrials.gov/study/NCT00575393","created_at":"2021-01-18T02:06:06.760Z","updated_at":"2024-07-02T16:37:06.359Z","phase":"Phase 1","brief_title":"Gold Sodium Thiomalate in Treating Patients With Advanced Non-Small Cell Lung Cancer","source_id_and_acronym":"NCT00575393","lead_sponsor":"Mayo Clinic","biomarkers":" PRKCH","pipe":"","alterations":" ","tags":["PRKCH"],"overall_status":"Completed","enrollment":" Enrollment 17","initiation":"Initiation: 01/25/2007","start_date":" 01/25/2007","primary_txt":" Primary completion: 06/30/2011","primary_completion_date":" 06/30/2011","study_txt":" Completion: 02/14/2012","study_completion_date":" 02/14/2012","last_update_posted":"2018-10-09"}]